Isaac Zacharias - 12 Jan 2024 Form 4 Insider Report for Shockwave Medical, Inc.

Role
President, CCO
Signature
/s/ Wade Estey, as attorney in fact for Isaac Zacharias
Issuer symbol
N/A
Transactions as of
12 Jan 2024
Net transactions value
-$567,478
Form type
4
Filing time
17 Jan 2024, 20:17:58 UTC
Previous filing
28 Dec 2023
Next filing
29 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Award $0 +7,506 +18% $0.000000 49,112 12 Jan 2024 Direct F1
transaction SWAV Common Stock Tax liability $662,976 -3,113 -6.3% $212.97 45,999 12 Jan 2024 Direct
transaction SWAV Common Stock Options Exercise $37,128 +9,222 +20% $4.03* 55,221 17 Jan 2024 Direct
transaction SWAV Common Stock Options Exercise $58,370 +8,699 +16% $6.71* 63,920 17 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -9,222 -100% $0.000000* 0 17 Jan 2024 Common Stock 9,222 $4.03 Direct F2
transaction SWAV Stock Option Options Exercise $0 -8,699 -22% $0.000000 31,709 17 Jan 2024 Common Stock 8,699 $6.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting and settlement of a performance-based restricted stock unit award granted on February 1, 2022, resulting from the achievement of certain performance criteria related to the compound annual growth rate of the Issuers revenue during the measurement period January 1, 2022 through December 31, 2023.
F2 Fully vested.